GB001

Gossamer Bio seeking out partners for failed DP2 antagonist, says it has 'viable path forward'
Fierce Biotech
Sun, 02/28/21 - 10:08 pm
Gossamer Bio
GB001
eosinophilic asthma
Despite Phase 2 Failure, Gossamer Bio Sees a Path for Drug in Asthma
Xconomy
Tue, 10/13/20 - 09:49 pm
Gossamer Bio
clinical trials
asthma
eosinophilic asthma
GB001